CMS Open Payments records what drug and device companies report paying U.S. physicians and teaching hospitals, including meals, fees, travel, royalties, and research funding. Reported payments totaled $78 billion from 2018 to 2024. Select a state or search any doctor by name.
Analysis by Matthew Hanauer, PhD, Chief Technology Officer at Civly · built from the complete CMS Open Payments release, program years 2018–2024.
Source: CMS Open Payments, loaded by Civly · program years 2018–2024. States shaded by total reported payments. Hover for detail; click a state to open its full report.
Companies reported $78 billion between 2018 and 2024. Most is research funding routed to hospitals and trial sites; $22.8 billion went out as general payments — the meals, fees, trips, and royalties that land in an individual doctor's record.
2018–2024 payments by type. Research funding, mainly for institutions and clinical trials, accounts for most reported dollars.
physicians and teaching hospitals took at least one payment.
individual transfers — from $12 lunches to multimillion-dollar royalty checks.
The largest payers are pharmaceutical and vaccine companies. The largest individual recipients include device inventors receiving royalties. Select a state on the map to see its payers and recipients.
Search a physician's name to see reported payment totals. Select a result to view the largest individual payments. The notes below explain how to interpret the records.
Results come from Civly's loaded copy of CMS Open Payments. Totals combine all reported program years on file. Being listed does not imply wrongdoing — most payments are routine (a sandwich at a lunch talk, a conference registration). Names can be shared by multiple physicians; confirm by city and specialty.
Open Payments records financial relationships between companies and healthcare providers. A reported payment alone does not indicate wrongdoing; consulting, speaking, and royalty arrangements can be legitimate.
Most reported dollars fund research at institutions and trial sites. General payments include meals, fees, travel, and royalties associated with individual physicians.
Figures come from the CMS Open Payments public dataset without adjustment. Each transaction includes a CMS record identifier.
Research including DeJong et al., JAMA Intern Med 2016 found an association between industry-sponsored meals and prescribing branded drugs. That finding does not establish the effect of a particular payment shown here.
Each state report includes payments by congressional district and county, leading payers and specialties, individual recipients, and a physician search.
Civly uses CMS Open Payments alongside other public records for research. Contact us for the underlying data, a state report, or a custom analysis.
Get in touch